Psittacosis (Chlamydophila psittaci)
Overview
Plain-Language Overview
Psittacosis is an infectious disease caused by the bacterium Chlamydophila psittaci, which primarily affects the lungs and respiratory system. It is often transmitted to humans from infected birds, especially parrots, pigeons, and poultry. The infection typically causes symptoms such as fever, cough, and difficulty breathing, resembling pneumonia. People with psittacosis may also experience headache, muscle aches, and fatigue. If untreated, the disease can lead to serious lung complications and systemic illness. Early recognition of symptoms related to bird exposure is important for diagnosis.
Clinical Definition
Psittacosis (also known as ornithosis) is a zoonotic infectious disease caused by the obligate intracellular bacterium Chlamydophila psittaci. The core pathology involves atypical pneumonia resulting from inhalation of aerosolized secretions or droppings from infected birds. The bacterium infects alveolar macrophages and respiratory epithelial cells, leading to a systemic inflammatory response. Clinically, it presents with high fever, nonproductive cough, and headache, often accompanied by hepatosplenomegaly and relative bradycardia. It is a significant cause of community-acquired pneumonia with potential for severe complications such as respiratory failure. Diagnosis and treatment are critical to prevent progression and systemic involvement.
Inciting Event
Inhalation of aerosolized secretions or dried droppings from infected birds initiates infection.
Handling or cleaning bird cages contaminated with C. psittaci triggers exposure.
Exposure to wild or domestic birds shedding the organism can cause disease.
Latency Period
Incubation period typically ranges from 5 to 14 days after exposure.
Symptoms usually develop within 1 to 2 weeks following inhalation of the pathogen.
Diagnostic Delay
Nonspecific flu-like symptoms often lead to misdiagnosis as viral respiratory infection.
Lack of awareness of bird exposure history delays consideration of psittacosis.
Limited availability of specific serologic or PCR testing can postpone diagnosis.
Overlap with atypical pneumonia caused by other pathogens complicates early identification.
Clinical Presentation
Signs & Symptoms
High fever with chills and headache
Nonproductive cough and dyspnea
Myalgia and malaise are common systemic symptoms
Dry cough often precedes pneumonia symptoms
Gastrointestinal symptoms such as nausea, vomiting, and diarrhea may occur
History of Present Illness
Initial presentation includes high fever, headache, and myalgia progressing over several days.
Dry cough and dyspnea develop as pneumonia ensues.
Patients may report chills, sweats, and malaise with gradual worsening respiratory symptoms.
Extrapulmonary symptoms such as hepatosplenomegaly or conjunctivitis can occur.
Past Medical History
History of chronic lung disease may worsen clinical course.
Previous immunosuppressive therapy can increase risk of severe infection.
Prior bird exposure or avian pet ownership is relevant for risk assessment.
Family History
No known heritable predisposition or familial syndromes associated with psittacosis.
Family members may share exposure risk if living in the same environment with infected birds.
Physical Exam Findings
Fever and tachypnea with signs of respiratory distress
Crackles or rales on lung auscultation indicating pneumonia
Conjunctival injection or mild conjunctivitis in some cases
Hepatomegaly or splenomegaly may be present due to systemic involvement
Relative bradycardia (Faget sign) despite high fever
Diagnostic Workup
Diagnostic Criteria
Diagnosis of psittacosis is established by a combination of clinical suspicion based on exposure history to birds and presentation with atypical pneumonia symptoms. Confirmatory diagnosis relies on serologic testing demonstrating a fourfold rise in antibody titers against Chlamydophila psittaci or detection of bacterial DNA by PCR from respiratory specimens. Culture is rarely performed due to biosafety risks. Chest imaging typically shows patchy infiltrates consistent with atypical pneumonia. Elevated liver enzymes and leukocytosis may support the diagnosis but are nonspecific.
Pathophysiology
Key Mechanisms
Intracellular infection of respiratory epithelial cells by Chlamydophila psittaci leads to host immune activation.
Inflammatory response causes alveolar damage and interstitial pneumonia.
Endotoxin release from bacteria contributes to systemic symptoms such as fever and malaise.
Immune-mediated tissue injury results in consolidation and potential extrapulmonary manifestations.
| Involvement | Details |
|---|---|
| Organs | Lungs are the main organs affected, presenting with atypical pneumonia symptoms. |
Liver may be involved causing mild hepatitis in some cases of psittacosis. | |
| Tissues | Alveolar tissue is the primary site of infection and inflammation causing pneumonia in psittacosis. |
| Cells | Alveolar macrophages phagocytose Chlamydophila psittaci and initiate the immune response. |
Neutrophils infiltrate lung tissue contributing to inflammation and tissue damage. | |
| Chemical Mediators | Interleukin-1 (IL-1) mediates fever and systemic inflammatory response in psittacosis. |
Tumor necrosis factor-alpha (TNF-α) promotes pulmonary inflammation and tissue injury. |
Treatments
Pharmacological Treatments
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Chlamydophila psittaci.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
First-line
Macrolides (e.g., Azithromycin)
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Chlamydophila psittaci.
- Side effects:
Gastrointestinal upset
QT prolongation
Hepatotoxicity
- Clinical role:
Second-line
Non-pharmacological Treatments
Supportive care including oxygen therapy for hypoxemia in severe cases.
Avoidance of exposure to infected birds to prevent reinfection.
Prevention
Pharmacological Prevention
Doxycycline prophylaxis is not routinely recommended but may be considered in high-risk exposures
No vaccine available for psittacosis prevention
Non-pharmacological Prevention
Avoidance of exposure to infected birds or contaminated bird droppings
Use of protective masks and gloves when handling birds
Proper cleaning and disinfection of bird cages and aviaries
Quarantine and veterinary screening of pet birds to reduce transmission risk
Outcome & Complications
Complications
Severe pneumonia with respiratory failure
Hepatitis due to systemic dissemination
Endocarditis in rare cases
Neurologic complications such as encephalitis or meningitis
Reactive arthritis as a post-infectious complication
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Psittacosis (Chlamydophila psittaci) versus Legionnaires' Disease
Psittacosis (Chlamydophila psittaci) | Legionnaires' Disease |
|---|---|
Exposure to infected birds or bird droppings | Exposure to contaminated water sources such as air conditioning systems or hot tubs |
Infection caused by Chlamydophila psittaci, an obligate intracellular gram-negative bacterium | Infection caused by Legionella pneumophila, a gram-negative bacillus |
Positive serology or PCR for Chlamydophila psittaci | Positive urinary antigen test for Legionella |
Psittacosis (Chlamydophila psittaci) versus Mycoplasma pneumoniae Pneumonia
Psittacosis (Chlamydophila psittaci) | Mycoplasma pneumoniae Pneumonia |
|---|---|
Can affect all ages but often linked to bird exposure | Common in children and young adults |
Caused by Chlamydophila psittaci, an intracellular bacterium | Caused by Mycoplasma pneumoniae, lacking a cell wall |
Responds well to tetracyclines, especially doxycycline | Responds well to macrolides or tetracyclines |
Psittacosis (Chlamydophila psittaci) versus Influenza Pneumonia
Psittacosis (Chlamydophila psittaci) | Influenza Pneumonia |
|---|---|
Gradual onset with atypical pneumonia symptoms and bird exposure | Abrupt onset with systemic symptoms like high fever, myalgia, and cough |
Negative influenza tests; positive serology or PCR for Chlamydophila psittaci | Positive rapid influenza antigen or PCR test |
Requires antibiotic treatment with tetracyclines | Responds to antiviral agents such as oseltamivir |
Psittacosis (Chlamydophila psittaci) versus Q Fever (Coxiella burnetii)
Psittacosis (Chlamydophila psittaci) | Q Fever (Coxiella burnetii) |
|---|---|
Exposure to birds or bird droppings | Exposure to farm animals like sheep, goats, or cattle |
Caused by Chlamydophila psittaci, an obligate intracellular bacterium | Caused by Coxiella burnetii, an obligate intracellular bacterium |
Positive serology or PCR specific for Chlamydophila psittaci | Positive phase I and II antibody serology for Coxiella burnetii |
Psittacosis (Chlamydophila psittaci) versus Community-Acquired Bacterial Pneumonia (e.g., Streptococcus pneumoniae)
Psittacosis (Chlamydophila psittaci) | Community-Acquired Bacterial Pneumonia (e.g., Streptococcus pneumoniae) |
|---|---|
Subacute onset with dry cough, headache, and atypical pneumonia pattern | Acute onset with high fever, productive cough, and lobar consolidation |
Diffuse interstitial or patchy infiltrates on chest X-ray | Lobar consolidation on chest X-ray |
Requires tetracyclines or macrolides for effective treatment | Responds to beta-lactam antibiotics |